Multiple Sclerosis: all 3,524 studies
Page 30 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple SclerosisCompletedNCT01895439Phase 1/2
- Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple SclerosisStatus unknownNCT01891071Not applicable
- Extension Study of MT-1303CompletedNCT01890655Phase 2
- Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS ExacerbationsCompletedNCT01888354Phase 4
- PK and PD Study of Natalizumab in Pediatric Subjects With RRMSCompletedNCT01884935Phase 1
- Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)Status unknownNCT01883661Phase 1/2
- Task-oriented Circuit Training Combined With Cerebellar tDCS in Multiple Sclerosis SubjectsCompletedNCT01883310Not applicable
- Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 MonthsCompletedNCT01881191
- Methylphenidate as Treatment Option of Fatigue in Multiple SclerosisStatus unknownNCT01879202Phase 2
- A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis PatientsCompletedNCT01871818Not applicable
- Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS)CompletedNCT01871337Not applicable
- Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.WithdrawnNCT01868048Phase 3
- Rehabilitation Protocol for Disorders on Hand Sensitivity in Multiple Sclerosis Patients.TerminatedNCT01866878Not applicable
- Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRICompletedNCT01865357Not applicable
- Interventional Clinical Trial for CCSVI in Multiple Sclerosis PatientsCompletedNCT01864941Phase 1/2
- Acupuncture or MBSR for Patients With Fatigue and MSCompletedNCT01864707Not applicable
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedNCT01863888Phase 3
- Avonex®: Safety, Blood Levels and EffectsCompletedNCT01863069Phase 1
- MEsenchymal StEm Cells for Multiple SclerosisStatus unknownNCT01854957Phase 1/2
- Natural History of Optic NeuritisTerminatedNCT01851434
- Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple SclerosisCompletedNCT01848327Not applicable
- A Longitudinal Study of Brain Atrophy in MS Patients Over 5 YearsCompletedNCT01847287
- Sodium Intake in Multiple SclerosisCompletedNCT01846234
- Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple SclerosisCompletedNCT01845896Not applicable
- One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With SpasticityCompletedNCT01844232Phase 3
- Efficacy of Fish Oil in Multiple SclerosisCompletedNCT01842191Phase 4
- Applying Speed of Processing Training to Individuals With Multiple SclerosisCompletedNCT01838824Not applicable
- An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT01838668Phase 3
- A Trial of Neuroprotection With ACTH in Acute Optic NeuritisTerminatedNCT01838174Phase 4
- Project FARMS: Fall Risk Reduction in Multiple SclerosisCompletedNCT01837017Phase 1
- Imaging Multiple Sclerosis Lesions Using Magnevist and GadavistTerminatedNCT01836055
- Pilot Study of Free From Falls Program in Multiple SclerosisCompletedNCT01829776Not applicable
- Home Exercise Intervention in Persons With Multiple SclerosisCompletedNCT01824550Not applicable
- Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated SyndromeCompletedNCT01817166Phase 3
- The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis PatientsCompletedNCT01816100Not applicable
- Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)Status unknownNCT01815632Phase 2
- A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple SclerosisStatus unknownNCT01811290
- Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.CompletedNCT01808885Phase 1
- A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)TerminatedNCT01808482Phase 1
- Investigation of GM Pathology Using Ultra High Field (7T) MRI ScannerStatus unknownNCT01805986
- Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal PopulationCompletedNCT01804660
- Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis DiseaseCompletedNCT01804647
- An Intravenous Infusion Study of rHIgM22 in Patients With Multiple SclerosisCompletedNCT01803867Phase 1
- GSK239512 DDI StudyCompletedNCT01802931Phase 1
- Amiloride Clinical Trial In Optic NeuritisCompletedNCT01802489Phase 2
- Power Over Pain (POP) StudyCompletedNCT01800604Not applicable
- Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple SclerosisCompletedNCT01795872Phase 4
- Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With FingolimodTerminatedNCT01790269
- Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal SpasticityStatus unknownNCT01786005Phase 4
- The Effect of Aerobic Exercise on Cognitive Function and Sleep Quality in Individuals With Multiple SclerosisCompletedNCT01783665Not applicable
- Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple SclerosisCompletedNCT01780792Not applicable
- Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK StudyCompletedNCT01776060
- Health Promotion and Wellness Program for Adults With Disabling ConditionsCompletedNCT01776034Not applicable
- Respiratory Function and Walking Capacity in Multiple SclerosisCompletedNCT01774201Not applicable
- Optical Coherence Tomography in Multiple Sclerosis PatientsCompletedNCT01774123
- Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple SclerosisCompletedNCT01772199Phase 2
- Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder DysfunctionCompletedNCT01768910Not applicable
- Vitamine D in Multiple SclerosisStatus unknownNCT01768039Phase 3
- Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on BetaferonCompletedNCT01766063
- Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)CompletedNCT01765361
- Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MSCompletedNCT01764737Phase 1
- Effects of Cognitive Behavioural Therapy and Exercise on Stress and Cognitive Deficits in Multiple SclerosisCompletedNCT01763983Not applicable
- Expiratory Muscle Conditioning in Multiple Sclerosis Using Magnetic StimulationCompletedNCT01758224Not applicable
- Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple SclerosisTerminatedNCT01755871Phase 4
- Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple SclerosisStatus unknownNCT01753375Phase 2
- Exercise in Severely Disabled Patients With MSCompletedNCT01752660Phase 1
- Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple SclerosisCompletedNCT01749943
- Sleep Apnea in Multiple Sclerosis Positive Airway Pressure TrialCompletedNCT01746342Not applicable
- Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple SclerosisCompletedNCT01745783Phase 1/2
- The Efficacy of EMDR in Patients With PTSD in Multiple SclerosisStatus unknownNCT01743664Phase 3
- Efficacy Study of Arbaclofen to Treat Spasticity in Multiple SclerosisCompletedNCT01743651Phase 3
- Dose-finding Study of MT-1303CompletedNCT01742052Phase 2
- A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple SclerosisCompletedNCT01737372
- Mesenchymal Stem Cells for Multiple SclerosisCompletedNCT01730547Phase 1/2
- Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated SyndromeCompletedNCT01728922Phase 1/2
- The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis CohortCompletedNCT01723709
- Analyze the Myelin-TRAP as Diagnostic Tool in Multiple SclerosisTerminatedNCT01723631Not applicable
- Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple SclerosisStatus unknownNCT01720849
- Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple SclerosisCompletedNCT01719159Phase 2
- Effect of Melatonin on Multiple Sclerosis Related FatigueCompletedNCT01718678Phase 2
- Rehabilitation in Multiple Sclerosis: Influence of Exercise on Development of Insulin Resistance, Muscle Power and Aerobic CapacityCompletedNCT01718392Not applicable
- Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT01717664Phase 2
- Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple SclerosisWithdrawnNCT01714089Phase 2
- Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple SclerosisTerminatedNCT01712945Phase 1/2
- Ginseng in Treatment of Fatigue in Multiple SclerosisCompletedNCT01712373Phase 2
- Evaluation of Coagulation in Multiple SclerosisCompletedNCT01711255
- Alternative Treatment Paradigm for Natalizumab TrialWithdrawnNCT01710228Phase 2
- Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMSWithdrawnNCT01709812Phase 4
- Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis ParticipantsTerminatedNCT01706107
- Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)CompletedNCT01706055
- Impact of Vitamin A on RAR Gene Expression in Multiple SclerosisStatus unknownNCT01705457Phase 4
- Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple SclerosisCompletedNCT01704183
- Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple SclerosisTerminatedNCT01701856Phase 4
- First-in-Human Study With GNbAC1 in Healthy VolunteersCompletedNCT01699555Phase 1
- Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial)CompletedNCT01698086Not applicable
- A Longitudinal Study of Effect of Copaxone in RRMS Over 24 MonthsCompletedNCT01695434
- Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisCompletedNCT01684761Phase 2
- High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior TreatmentTerminatedNCT01679041Phase 2
- Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?CompletedNCT01667497Phase 2/3
- Adderall XR and Processing Speed in Multiple Sclerosis (MS)CompletedNCT01667484Phase 2/3